MA

Machha Ashwini

Active Director Director DIN 10270381
DIN 10270381 First appointment Apr 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value •••• Premium profile

About Machha Ashwini

Data last updated:

Machha Ashwini is a Director at Biomel Remedies Private Limited (since 2024). Biomel Remedies Private Limited reported revenue of ₹3.9 Lakh (FY 2024).

DIN 10270381
Primary Designation Director
First Appointment 05 Apr 2024
Oldest Company Age 3 yrs
Largest company Biomel Remedies Private Limited · ₹3.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biomel Remedies Private Limited U47721TS2023PTC172294
Director05 Apr 20242023₹3.9 Lakh (FY 2024)Active

Board colleagues of Machha Ashwini

NameDINCompanyDesignation
Machha Siddiraju10131692Biomel Remedies Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Biomel Remedies Private Limited
Premium access

Shareholding and investment profile for Machha Ashwini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Machha Ashwini

Machha Ashwini currently holds 1 directorship: Biomel Remedies Private Limited (Director, since 05 Apr 2024, revenue ₹3.9 Lakh (FY 2024)).

Machha Ashwini was first appointed on 05 Apr 2024 as Director at Biomel Remedies Private Limited.

The current boards of Machha Ashwini's companies include Machha Siddiraju (Biomel Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available